"Daughter" PUBLIC JOINT-STOCK COMPANY JOINT-STOCK FINANCIAL CORPORATION "SISTEMA" let out technology for productions a cancer medicine

Now the majority of the Russian companies Belonging PUBLIC JOINT-STOCK COMPANY JOINT-STOCK FINANCIAL CORPORATION "SISTEMA" LLC "SISTEMA-BIOTEKH" importozamestila technology production of recombinant therapeutic proteins for this purpose uses import development. director general reported companies to "Sheets" about it Artem Sirazutdinov. Such proteins are used for productions biotechnological preparations on the basis of monoclonal antibodies (the antibodies developed in laboratory). In particular they are applied at treatment of autoimmune diseases and oncology. Commercially proteins are grown up in bioreactors with help the special...